Therapeutic HPV vaccines

被引：86

作者：

Hancock, Gemma ^{[1
,2
]}

Hellner, Karin ^{[3
]}

Dorrell, Lucy ^{[1
,2
,3
]}

机构：

[1] Univ Oxford, Nuffield Dept Med, NDM Res Bldg,Old Rd Campus, Oxford, England

[2] Oxford NIHR Biomed Res Ctr, NDM Res Bldg,Old Rd Campus, Oxford, England

[3] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Womens Ctr, Oxford, England

来源：

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY | 2018年 / 47卷

关键词：

High-risk human papillomavirus; HPV-Associated malignancies; Therapeutic vaccine; Viral vector; DNA vaccine; Bacterial vector; CERVICAL INTRAEPITHELIAL NEOPLASIA; REGULATORY T-CELLS; HUMAN-PAPILLOMAVIRUS TYPE-16; PLASMID DNA VACCINES; AGED; 16-26; YEARS; PARTICLE VACCINE; MVA E2; INTRAMUSCULAR INJECTION; SPONTANEOUS REGRESSION; ANTIGEN PRESENTATION;

D O I：

10.1016/j.bpobgyn.2017.09.008

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

High-risk human papillomavirus (HPV) infection is known to be a necessary factor for cervical and anogenital malignancies. Cervical cancers account for over a quarter of a million deaths annually. Despite the availability of prophylactic vaccines, HPV infections remain extremely common worldwide. Furthermore, these vaccines are ineffective at clearing pre-existing infections and associated preinvasive lesions. As cervical dysplasia can regress spontaneously, a therapeutic HPV vaccine that boosts host immunity could have a significant impact on the morbidity and mortality associated with HPV. Therapeutic vaccines differ from prophylactic vaccines in that they are aimed at generating cell mediated immunity rather than neutralising antibodies. This review will cover various therapeutic vaccine strategies in development for the treatment of HPV-associated lesions and cancers. (C) 2017 Elsevier Ltd. All rights reserved.

引用

页码：59 / 72

页数：14

共 88 条

[1] MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma - A phase I/II study [J].

Albarran y Carvajal, Antonio ;

de la Garza, Alfonso ;

Cecilio Cruz Quiroz, Benitez Jose ;

Zea, Eduardo Vazquez ;

Estrada, Ismael Diaz ;

Fuentez, Ernesto Mendez ;

Contreras, Mario Lopez ;

Andrade-Manzano, Alejandro ;

Padilla, Santiago ;

Varela, Axel Ramirez ;

Rosales, Ricardo .

BIODRUGS, 2007, 21 (01) :47-59

[2]

[Anonymous], 2017, STRAT ADV GROUP EXP

[3]

[Anonymous], COCHRANE DATABASE SY

[4]

[Anonymous], GEN REP FIN RES GTL0

[5] Cytoplasmic DNA innate immune pathways [J].

Barber, Glen N. .

IMMUNOLOGICAL REVIEWS, 2011, 243 :99-108

[6] Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation [J].

Bijker, Martijn S. ;

van den Eeden, Susan J. E. ;

Franken, Kees L. ;

Melief, Cornelis J. M. ;

van der Burg, Sjoerd H. ;

Offringa, Rienk .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (04) :1033-1042

[7] Neoantigen-based cancer immunotherapy [J].

Bobisse, Sara ;

Foukas, Periklis G. ;

Coukos, George ;

Harari, Alexandre .

ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (14)

[8] The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years [J].

Brown, Darron R. ;

Kjaer, Susanne K. ;

Sigurdsson, Kristjan ;

Iversen, Ole-Erik ;

Hernandez-Avila, Mauricio ;

Wheeler, Cosette M. ;

Perez, Gonzalo ;

Koutsky, Laura A. ;

Tay, Eng Hseon ;

Garcia, Patricia ;

Ault, Kevin A. ;

Garland, Suzanne M. ;

Leodolter, Sepp ;

Olsson, Sven-Eric ;

Tang, Grace W. K. ;

Ferris, Daron G. ;

Paavonen, Jorma ;

Steben, Marc ;

Bosch, F. Xavier ;

Dillner, Joakim ;

Joura, Elmar A. ;

Kurman, Robert J. ;

Majewski, Slawomir ;

Munoz, Nubia ;

Myers, Evan R. ;

Villa, Luisa L. ;

Taddeo, Frank J. ;

Roberts, Christine ;

Tadesse, Amha ;

Bryan, Janine ;

Lupinacci, Lisa C. ;

Giacoletti, Katherine E. D. ;

Sings, Heather L. ;

James, Margaret ;

Hesley, Teresa M. ;

Barra, Eliav .

JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (07) :926-935

[9] Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy [J].

Brun, Jean-Luc ;

Dalstein, Veronique ;

Leveque, Jean ;

Mathevet, Patrice ;

Raulic, Patrick ;

Baldauf, Jean-Jacques ;

Scholl, Suzy ;

Huynh, Bernard ;

Douvier, Serge ;

Riethmuller, Didier ;

Clavel, Christine ;

Birembaut, Philippe ;

Calenda, Valerie ;

Baudin, Martine ;

Bory, Jean-Paul .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 (02) :169.e1-169.e8

[10] Local accumulation of FOXP3+ regulatory T cells:: Evidence for an immune evasion mechanism in patients with large condylomata acuminata [J].

Cao, Yuchun ;

Zhao, Jie ;

Lei, Zhang ;

Shen, Shiqian ;

Liu, Cong ;

Li, Dong ;

Liu, Jihong ;

Shen, Guan-Xin ;

Zhang, Gui-Mei ;

Feng, Zuo-Hua ;

Huang, Bo .

JOURNAL OF IMMUNOLOGY, 2008, 180 (11) :7681-7686

← 1 2 3 4 5 6 7 8 9 →